LSAE Publication Sources Tool

Gyapong JO, Adjei S, Gyapong M, Asamoah G. Rapid community diagnosis of lymphatic filariasis. Addict Behav Rep. 1996; 61(1): 65-74.

Omudu EA, Okafor FC. Rapid epidemiological and Socio-cultural appraisal of lymphatic filariasis amongst the Igede ethnic group in Benue State, Nigeria. Niger J Parasitol. 2007; 28(2): 118-123.

Modi A, Gamit S, Jesalpura BS, Kurien G, Kosambiya JK. Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India. PLoS Negl Trop Dis. 2017; 11(4): e0005476.

Rao RU, Samarasekera SD, Nagodavithana KC, Dassanayaka TDM, Punchihewa MW, Ranasinghe USB, Weil GJ. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka. PLoS Negl Trop Dis. 2017; 11(10): e0006066.

Nicolas L, Plichart C, Nguyen LN, Moulia-Pelat JP. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. J Infect Dis. 1997; 175(2): 489-92.

Terhell AJ, Stolk WA, Haarbrink M, Mangali A, Van Oortmarssen GJ, Yazdanbakhsh M. Regulation of anti-filarial IgE by infection pressure. Parasitology. 2002; 124(Pt 5): 509-19.

Supali T, Djuardi Y, Wibowo H, van Ree R, Yazdanbakhsh M, Sartono E. Relationship between Different Species of Helminths and Atopy: A Study in a Population Living in Helminth-Endemic Area in Sulawesi, Indonesia. Int Arch Allergy Immunol. 2010; 153(4): 388-94.

Kalimuthu M, Sunish IP, Nagaraj J, Munirathinam A, Kumar VA, Arunachalam N, White GB, Tyagi BK. Residual microfilaraemia in rural pockets of South India after five rounds of DEC plus albendazole administration as part of the LF elimination campaign. J Vector Borne Dis. 2015; 52(2): 182-4.

Champetier De Ribes G, Ranaivoson G, Rakotoherisoa E, Ramanampamonjy R, Randrianirina F. Résultats préliminaires de l'enquête épidémio-clinique et parasitologique sur la filariose de Bancroft à Madagascar. Arch Inst Pasteur Madagascar. 1996; 63(1-2): 16-8.

Chesnais CB, Awaca-Uvon NP, Vlaminck J, Tambwe JP, Weil GJ, Pion SD, Boussinesq M. Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo. Parasites Vectors. 2019; 12(1): 162.

Ivoke N. Rural bancroftian filariasis in north-western Cameroon: parasitological and clinical studies. J Commun Dis. 2000; 32(4): 254-63.

Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), Ministry of Health (Sao Tome and Principe), World Health Organization Regional Office for Africa (WHO-AFRO). Sao Tome and Principe Lymphatic Filariasis Site Level Map Data 2015-2022. Brazzaville, Congo: World Health Organization Regional Office for Africa (WHO-AFRO), 2018.

Drexler N, Washington CH, Lovegrove M, Grady C, Milord MD, Streit T, Lammie P. Secondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settings. PLoS Negl Trop Dis. 2012; 6(10): e1807.

Simonsen PE, Meyrowitsch DW, Makunde WH, Magnussen P. Selective diethylcarbamazine chemotherapy for control of Bancroftian filariasis in two communities of Tanzania: compared efficacy of a standard dose treatment and two semi-annual single dose treatments. Am J Trop Med Hyg. 1995; 53(3): 267-72.

Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), Ministry of Health and Social Action (Senegal), World Health Organization Regional Office for Africa (WHO-AFRO). Senegal Lymphatic Filariasis Site Level Map Data 1950-2023. Brazzaville, Congo: World Health Organization Regional Office for Africa (WHO-AFRO), 2018.

Singh BK, Bockarie MJ, Gambhir M, Siba PM, Tisch DJ, Kazura J, Michael E. Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea. PLoS One. 2013; 8(6): e67004.

Kyelem D, Medlock J, Sanou S, Bonkoungou M, Boatin B, Molyneux DH. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia. Trop Med Int Health. 2005; 10(10): 1002-4.

Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), Ministry of Health and Sanitation (Sierra Leone), World Health Organization Regional Office for Africa (WHO-AFRO). Sierra Leone Lymphatic Filariasis Site Level Map Data 1922-2022. Brazzaville, Congo: World Health Organization Regional Office for Africa (WHO-AFRO), 2018.

Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), Ministry of Health (South Sudan), World Health Organization Regional Office for Africa (WHO-AFRO). South Sudan Lymphatic Filariasis Site Level Map Data 2009-2016. Brazzaville, Congo: World Health Organization Regional Office for Africa (WHO-AFRO), 2018.

Washington CH, Radday J, Streit TG, Boyd HA, Beach MJ, Addiss DG, Lovince R, Lovegrove MC, Lafontant JG, Lammie PJ, Hightower AW. Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence. Filaria J. 2004; 3(1): 3-3.

World Health Organization Regional Office for South-East Asia (SEARO). Sri Lanka - Expert Mission to Sri Lanka for Verification of Elimination of Lymphatic Filariasis. New Delhi, India: World Health Organization Regional Office for South-East Asia (SEARO), 2011.

Mukhopadhyay AK, Patnaik SK, Babu PS. Status of lymphatic filariasis in parts of east Godavari district of Andhra Pradesh, India. J Vector Borne Dis. 2007; 44(1): 72-4.

Raina VK, Tripathi VC, Ram R, Kumar A, Verghese T. Status of lymphatic filariasis in some select slum clusters of Delhi. J Commun Dis. 1992; 24(2): 92-6.

Anosike JC, Onwuliri CO. Studies on filariasis in Bauchi State, Nigeria. II. The prevalence of human filariasis in Darazo Local Government area. Appl Parasitol. 1994; 35(4): 242-50.

Ebenezer A, Amadi EC, Agi PI. Studies on the microfilaria, antigenemia and clinical signs of bancroftian filariasis in Epie creek communities, Niger Delta, Nigeria. Int Res J Microbiol. 2011; 2(9): 370-4.